A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix.

Trial Profile

A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 May 2009

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Uterine cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 May 2009 Actual initiation date (Jan 2005) added as reported by ClinicalTrials.gov.
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top